Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1993 May;61(5):2108–2115. doi: 10.1128/iai.61.5.2108-2115.1993

Specificity of S fimbriae on recombinant Escherichia coli: preferential binding to gangliosides expressing NeuGc alpha (2-3)Gal and NeuAc alpha (2-8)NeuAc.

F G Hanisch 1, J Hacker 1, H Schroten 1
PMCID: PMC280810  PMID: 8097494

Abstract

The adhesins of Escherichia coli strains HB101(pANN801-13) and HB101(pAZZ50), which express S fimbriae encoded by a recombinant plasmid containing the sfaI and sfaII gene clusters, respectively, were characterized with regard to the detailed structural requirements of their binding to sialyloligosaccharides on (neo)glycoproteins and (neo)glycolipids. From binding and binding inhibition studies in solid-phase enzyme immunoassays with isolated S fimbriae, several major conclusions can be drawn. S fimbriae bind specifically to sialic acid on gangliosides. The most active structural variant of sialic acid on GM3 ganglioside is N-glycolylneuraminic acid (NeuGc). In contrast to previous reports, high binding activities were measured also for b-series gangliosides expressing NeuAc alpha (2-8)NeuAc. In agreement with earlier studies, the site of sialic acid substitution to subterminal sugars strongly influences the binding to sialyloligosaccharides, i.e., alpha-6-linked sialic acid is only poorly recognized by the adhesin compared with alpha-3-linked sialic acid. C-8 and C-9 hydroxyl groups form essential structural elements of sialic acid in the binding event.

Full text

PDF
2108

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AMINOFF D. Methods for the quantitative estimation of N-acetylneuraminic acid and their application to hydrolysates of sialomucoids. Biochem J. 1961 Nov;81:384–392. doi: 10.1042/bj0810384. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Beachey E. H. Bacterial adherence: adhesin-receptor interactions mediating the attachment of bacteria to mucosal surface. J Infect Dis. 1981 Mar;143(3):325–345. doi: 10.1093/infdis/143.3.325. [DOI] [PubMed] [Google Scholar]
  3. Egge H., Peter-Katalinić J., Paz-Parente J., Strecker G., Montreuil J., Fournet B. Carbohydrate structures of hen ovomucoid. A mass spectrometric analysis. FEBS Lett. 1983 Jun 13;156(2):357–362. doi: 10.1016/0014-5793(83)80528-6. [DOI] [PubMed] [Google Scholar]
  4. Finne J. Occurrence of unique polysialosyl carbohydrate units in glycoproteins of developing brain. J Biol Chem. 1982 Oct 25;257(20):11966–11970. [PubMed] [Google Scholar]
  5. Gladstone I. M., Ehrenkranz R. A., Edberg S. C., Baltimore R. S. A ten-year review of neonatal sepsis and comparison with the previous fifty-year experience. Pediatr Infect Dis J. 1990 Nov;9(11):819–825. doi: 10.1097/00006454-199011000-00009. [DOI] [PubMed] [Google Scholar]
  6. Hacker J., Schmidt G., Hughes C., Knapp S., Marget M., Goebel W. Cloning and characterization of genes involved in production of mannose-resistant, neuraminidase-susceptible (X) fimbriae from a uropathogenic O6:K15:H31 Escherichia coli strain. Infect Immun. 1985 Feb;47(2):434–440. doi: 10.1128/iai.47.2.434-440.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hirabayashi Y., Kasakura H., Matsumoto M., Higashi H., Kato S., Kasai N., Naiki M. Specific expression of unusual GM2 ganglioside with Hanganutziu-Deicher antigen activity on human colon cancers. Jpn J Cancer Res. 1987 Mar;78(3):251–260. [PubMed] [Google Scholar]
  8. KLENK E., UHLENBRUCK G. [On the isolation of mucoids containing neuraminic acid from human erythrocyte stroma, a contribution to the chemistry of agglutinogens]. Hoppe Seylers Z Physiol Chem. 1960;319:151–160. doi: 10.1515/bchm2.1960.319.1.151. [DOI] [PubMed] [Google Scholar]
  9. Kawai T., Kato A., Higashi H., Kato S., Naiki M. Quantitative determination of N-glycolylneuraminic acid expression in human cancerous tissues and avian lymphoma cell lines as a tumor-associated sialic acid by gas chromatography-mass spectrometry. Cancer Res. 1991 Feb 15;51(4):1242–1246. [PubMed] [Google Scholar]
  10. Korhonen T. K., Valtonen M. V., Parkkinen J., Väisänen-Rhen V., Finne J., Orskov F., Orskov I., Svenson S. B., Mäkelä P. H. Serotypes, hemolysin production, and receptor recognition of Escherichia coli strains associated with neonatal sepsis and meningitis. Infect Immun. 1985 May;48(2):486–491. doi: 10.1128/iai.48.2.486-491.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Korhonen T. K., Väisänen-Rhen V., Rhen M., Pere A., Parkkinen J., Finne J. Escherichia coli fimbriae recognizing sialyl galactosides. J Bacteriol. 1984 Aug;159(2):762–766. doi: 10.1128/jb.159.2.762-766.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. McCracken G. H., Jr, Sarff L. D., Glode M. P., Mize S. G., Schiffer M. S., Robbins J. B., Gotschlich E. C., Orskov I., Orskov F. Relation between Escherichia coli K1 capsular polysaccharide antigen and clinical outcome in neonatal meningitis. Lancet. 1974 Aug 3;2(7875):246–250. doi: 10.1016/s0140-6736(74)91413-5. [DOI] [PubMed] [Google Scholar]
  13. Moch T., Hoschützky H., Hacker J., Kröncke K. D., Jann K. Isolation and characterization of the alpha-sialyl-beta-2,3-galactosyl-specific adhesin from fimbriated Escherichia coli. Proc Natl Acad Sci U S A. 1987 May;84(10):3462–3466. doi: 10.1073/pnas.84.10.3462. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Monsigny M., Petit C., Roche A. C. Colorimetric determination of neutral sugars by a resorcinol sulfuric acid micromethod. Anal Biochem. 1988 Dec;175(2):525–530. doi: 10.1016/0003-2697(88)90578-7. [DOI] [PubMed] [Google Scholar]
  15. Nohara-Uchida K., Ohashi M. Isolation and characterization of major gangliosides from frog liver. J Biochem. 1987 Oct;102(4):923–932. doi: 10.1093/oxfordjournals.jbchem.a122133. [DOI] [PubMed] [Google Scholar]
  16. Parkkinen J., Finne J., Achtman M., Väisänen V., Korhonen T. K. Escherichia coli strains binding neuraminyl alpha 2-3 galactosides. Biochem Biophys Res Commun. 1983 Mar 16;111(2):456–461. doi: 10.1016/0006-291x(83)90328-5. [DOI] [PubMed] [Google Scholar]
  17. Parkkinen J., Korhonen T. K., Pere A., Hacker J., Soinila S. Binding sites in the rat brain for Escherichia coli S fimbriae associated with neonatal meningitis. J Clin Invest. 1988 Mar;81(3):860–865. doi: 10.1172/JCI113395. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Parkkinen J., Rogers G. N., Korhonen T., Dahr W., Finne J. Identification of the O-linked sialyloligosaccharides of glycophorin A as the erythrocyte receptors for S-fimbriated Escherichia coli. Infect Immun. 1986 Oct;54(1):37–42. doi: 10.1128/iai.54.1.37-42.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Percy A. K., Gottfries J., Vilbergsson G., Månsson J. E., Svennerholm L. Glycosphingolipid glycosyltransferases in human fetal brain. J Neurochem. 1991 May;56(5):1461–1465. doi: 10.1111/j.1471-4159.1991.tb02038.x. [DOI] [PubMed] [Google Scholar]
  20. Reuter G., Schauer R., Szeiki C., Kamerling J. P., Vliegenthart J. F. A detailed study of the periodate oxidation of sialic acids in glycoproteins. Glycoconj J. 1989;6(1):35–44. doi: 10.1007/BF01047888. [DOI] [PubMed] [Google Scholar]
  21. Robbins J. B., McCracken G. H., Jr, Gotschlich E. C., Orskov F., Orskov I., Hanson L. A. Escherichia coli K1 capsular polysaccharide associated with neonatal meningitis. N Engl J Med. 1974 May 30;290(22):1216–1220. doi: 10.1056/NEJM197405302902202. [DOI] [PubMed] [Google Scholar]
  22. Salit I. E., Gotschlich E. C. Hemagglutination by purified type I Escherichia coli pili. J Exp Med. 1977 Nov 1;146(5):1169–1181. doi: 10.1084/jem.146.5.1169. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Stoll M. S., Hounsell E. F., Lawson A. M., Chai W. G., Ten F. Z. Microscale sequencing of O-linked oligosaccharides using mild periodate oxidation of alditols, coupling to phospholipid and TLC-MS analysis of the resulting neoglycolipids. Eur J Biochem. 1990 May 20;189(3):499–507. doi: 10.1111/j.1432-1033.1990.tb15515.x. [DOI] [PubMed] [Google Scholar]
  24. Svennerholm L., Boström K., Fredman P., Månsson J. E., Rosengren B., Rynmark B. M. Human brain gangliosides: developmental changes from early fetal stage to advanced age. Biochim Biophys Acta. 1989 Sep 25;1005(2):109–117. doi: 10.1016/0005-2760(89)90175-6. [DOI] [PubMed] [Google Scholar]
  25. Svennerholm L., Rynmark B. M., Vilbergsson G., Fredman P., Gottfries J., Månsson J. E., Percy A. Gangliosides in human fetal brain. J Neurochem. 1991 May;56(5):1763–1768. doi: 10.1111/j.1471-4159.1991.tb02078.x. [DOI] [PubMed] [Google Scholar]
  26. UHLENBRUCK G., SCHMITT J. UBER DAS VORKOMMEN VON N-GLYKOLYL-NEURAMINSAEURE BEI AFFEN. Naturwissenschaften. 1965 Apr;52:163–163. doi: 10.1007/BF00609282. [DOI] [PubMed] [Google Scholar]
  27. Wevers P., Picken R., Schmidt G., Jann B., Jann K., Golecki J. R., Kist M. Characterization of pili associated with Escherichia coli O18ac. Infect Immun. 1980 Aug;29(2):685–691. doi: 10.1128/iai.29.2.685-691.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES